BLUE

bluebird bio, Inc. BLUE

Trading inactive

BLUE
bluebird bio, Inc. SYRE
Spyre Therapeutics, Inc. GRNA
GreenLight Biosciences Holdings RENB
Lunai Bioworks Inc. ALVR
AlloVir, Inc. RNTX
Rein Therapeutics Inc. MGTA
Magenta Therapeutics, Inc. ERYP
ERYTECH Pharma S.A. KRON
Kronos Bio, Inc. TCRR
TCR2 Therapeutics Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BLUE SYRE GRNA RENB ALVR RNTX MGTA ERYP KRON TCRR
6M -42.81 % 60.77 % -57.26 % -60.56 % -44.83 % -9.36 % -10.43 % 31.98 % -11.13 % 48.18 %
YTD -42.81 % 2.66 % -73.96 % -81.39 % -5.22 % -31.11 % 70.63 % 128.54 % -9.29 % 48.00 %
1Y -73.08 % -24.73 % -92.26 % -73.70 % -43.65 % -26.89 % -35.82 % -23.53 % -29.60 % -48.97 %
3Y -95.08 % -4.91 % -96.94 % -93.00 % -91.91 % -26.89 % -90.60 % -88.95 % -83.27 % -90.36 %
5Y -99.35 % -86.76 % -96.94 % -95.34 % -98.32 % -26.89 % -92.28 % -92.98 % -96.75 % -90.18 %
10Y -99.76 % -89.98 % -96.94 % -97.59 % -98.32 % -26.89 % -95.18 % -96.80 % -96.75 % -90.18 %
From the beginning -98.57 % -89.98 % -96.94 % -97.59 % -98.32 % -26.89 % -95.18 % -96.80 % -96.75 % -90.18 %

Dividend